Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT05068115
  4. Details
NCT05068115 Clinical Trial

Characteristics and Treatment Trends of Young Breast Cancer in China

Breast Cancer Clinical Trial

Official title:
An Study on the Trend of Change and Influencing Factors of Clinicopathologic Characteristics, Diagnosis and Treatment Pattern, and Survival Status of Young Breast Cancer in China

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05068115
Other study ID # NCC2985
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 1, 2021
Est. completion date October 1, 2024

Study information
Verified date October 2021
Source Chinese Academy of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To describe the clinical characteristics, the diagnosis and treatment, the survival status and change trend of young breast cancer patients in China from 2000 to 2015, and to explore and discuss the main influencing factors.

Description:

In this study, medical records and follow-up information of young breast cancer patients (age ≤35 years at first diagnosis) who were first diagnosed and treated in the years (2000, 2003, 2006, 2009, 2012 and 2015) were collected from multiple hospitals in China from 2000 to 2015, to establish a retrospective cohort of young breast cancer patients. Clinical characteristics, diagnosis and treatment, and survival rates of young breast cancer patients from 2000 to 2015 were analyzed. To explore the main factors affecting the clinical diagnosis and treatment and the survival of patients.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1000
Est. completion date October 1, 2024
Est. primary completion date October 1, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Young Breast cancer patients (=35 years old) in China Exclusion Criteria: - Breast cancer patients (>35 years old) in China

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Clinical characteristics, diagnosis and treatment, survival status
Describe the clinical characteristics, diagnosis and treatment, survival status and the trends of young breast cancer

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Chinese Academy of Medical Sciences

Outcome
Type Measure Description Time frame Safety issue
Primary Clinical features and trend To describe the clinical characteristics and trends of young breast cancer patients in China Between 2000 and 2015
Primary Diagnosis and treatment and trend To describe the methods of diagnosis and treatment in young breast cancer patients in China and the changing trend, to explore the main factors affecting diagnosis and treatment Between 2000 and 2015
Primary Survival situation and change trend To describe the survival and change trend of young breast cancer patients in China, to explore the main factors affecting the prognosis of young breast cancer patients Between 2000 and 2015
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A